IBDEI16K ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,21105,0)
 ;;=238.74^^118^1266^9
 ;;^UTILITY(U,$J,358.3,21105,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,21105,1,1,0)
 ;;=1^238.74
 ;;^UTILITY(U,$J,358.3,21105,1,8,0)
 ;;=8^Myelody Synd w/ 5q Deletion
 ;;^UTILITY(U,$J,358.3,21105,2)
 ;;=^334030
 ;;^UTILITY(U,$J,358.3,21106,0)
 ;;=238.75^^118^1266^10
 ;;^UTILITY(U,$J,358.3,21106,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,21106,1,1,0)
 ;;=1^238.75
 ;;^UTILITY(U,$J,358.3,21106,1,8,0)
 ;;=8^Myelodysplastic Syndrome
 ;;^UTILITY(U,$J,358.3,21106,2)
 ;;=^334031
 ;;^UTILITY(U,$J,358.3,21107,0)
 ;;=238.76^^118^1266^11
 ;;^UTILITY(U,$J,358.3,21107,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,21107,1,1,0)
 ;;=1^238.76
 ;;^UTILITY(U,$J,358.3,21107,1,8,0)
 ;;=8^Myelofibrosis w/Myeloid Metaplasia
 ;;^UTILITY(U,$J,358.3,21107,2)
 ;;=^334032
 ;;^UTILITY(U,$J,358.3,21108,0)
 ;;=238.77^^118^1266^16
 ;;^UTILITY(U,$J,358.3,21108,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,21108,1,1,0)
 ;;=1^238.77
 ;;^UTILITY(U,$J,358.3,21108,1,8,0)
 ;;=8^Post Transp Lymphoprolif d/o PTLD
 ;;^UTILITY(U,$J,358.3,21108,2)
 ;;=^336526
 ;;^UTILITY(U,$J,358.3,21109,0)
 ;;=238.79^^118^1266^12
 ;;^UTILITY(U,$J,358.3,21109,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,21109,1,1,0)
 ;;=1^238.79
 ;;^UTILITY(U,$J,358.3,21109,1,8,0)
 ;;=8^Oth Lymph/Hematopoietic Tissue
 ;;^UTILITY(U,$J,358.3,21109,2)
 ;;=^334033
 ;;^UTILITY(U,$J,358.3,21110,0)
 ;;=238.8^^118^1266^13
 ;;^UTILITY(U,$J,358.3,21110,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,21110,1,1,0)
 ;;=1^238.8
 ;;^UTILITY(U,$J,358.3,21110,1,8,0)
 ;;=8^Oth Lymph/Hematopoietic Tissue NEC
 ;;^UTILITY(U,$J,358.3,21110,2)
 ;;=^267779
 ;;^UTILITY(U,$J,358.3,21111,0)
 ;;=238.9^^118^1266^8
 ;;^UTILITY(U,$J,358.3,21111,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,21111,1,1,0)
 ;;=1^238.9
 ;;^UTILITY(U,$J,358.3,21111,1,8,0)
 ;;=8^Lymph/Hematopoietic Tissue NOS
 ;;^UTILITY(U,$J,358.3,21111,2)
 ;;=^267780
 ;;^UTILITY(U,$J,358.3,21112,0)
 ;;=239.0^^118^1267^5
 ;;^UTILITY(U,$J,358.3,21112,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,21112,1,1,0)
 ;;=1^239.0
 ;;^UTILITY(U,$J,358.3,21112,1,8,0)
 ;;=8^Digestive Neoplasm NOS
 ;;^UTILITY(U,$J,358.3,21112,2)
 ;;=^267781
 ;;^UTILITY(U,$J,358.3,21113,0)
 ;;=239.1^^118^1267^11
 ;;^UTILITY(U,$J,358.3,21113,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,21113,1,1,0)
 ;;=1^239.1
 ;;^UTILITY(U,$J,358.3,21113,1,8,0)
 ;;=8^Respiratory Neoplasm NOS
 ;;^UTILITY(U,$J,358.3,21113,2)
 ;;=^267782
 ;;^UTILITY(U,$J,358.3,21114,0)
 ;;=239.2^^118^1267^2
 ;;^UTILITY(U,$J,358.3,21114,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,21114,1,1,0)
 ;;=1^239.2
 ;;^UTILITY(U,$J,358.3,21114,1,8,0)
 ;;=8^Bone,Soft Tissue,Skin Neoplasm NOS
 ;;^UTILITY(U,$J,358.3,21114,2)
 ;;=^267783
 ;;^UTILITY(U,$J,358.3,21115,0)
 ;;=239.3^^118^1267^4
 ;;^UTILITY(U,$J,358.3,21115,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,21115,1,1,0)
 ;;=1^239.3
 ;;^UTILITY(U,$J,358.3,21115,1,8,0)
 ;;=8^Breast Neoplasm NOS
 ;;^UTILITY(U,$J,358.3,21115,2)
 ;;=^81977
 ;;^UTILITY(U,$J,358.3,21116,0)
 ;;=239.4^^118^1267^1
 ;;^UTILITY(U,$J,358.3,21116,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,21116,1,1,0)
 ;;=1^239.4
 ;;^UTILITY(U,$J,358.3,21116,1,8,0)
 ;;=8^Bladder Neoplasm NOS
 ;;^UTILITY(U,$J,358.3,21116,2)
 ;;=^81975
 ;;^UTILITY(U,$J,358.3,21117,0)
 ;;=239.5^^118^1267^9
 ;;^UTILITY(U,$J,358.3,21117,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,21117,1,1,0)
 ;;=1^239.5
 ;;^UTILITY(U,$J,358.3,21117,1,8,0)
 ;;=8^Oth Genitourinary Org Neoplasm NOS
 ;;^UTILITY(U,$J,358.3,21117,2)
 ;;=^267784
 ;;^UTILITY(U,$J,358.3,21118,0)
 ;;=239.6^^118^1267^3
 ;;^UTILITY(U,$J,358.3,21118,1,0)
 ;;=^358.31IA^8^2
